Total Payments
$65,650
2024 Payments
$10,226
Companies
59
Transactions
904
Medicare Patients
3,299
Medicare Billing
$326,788
Payment Breakdown by Category
Other$39,095 (59.6%)
Food & Beverage$21,095 (32.1%)
Consulting$4,669 (7.1%)
Education$567.71 (0.9%)
Travel$203.74 (0.3%)
Gifts$19.74 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,795 | 21 | 53.0% |
| Food and Beverage | $21,095 | 844 | 32.1% |
| Consulting Fee | $4,669 | 5 | 7.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,300 | 3 | 6.5% |
| Education | $567.71 | 14 | 0.9% |
| Travel and Lodging | $203.74 | 12 | 0.3% |
| Gift | $19.74 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $23,963 | 265 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $5,410 | 52 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $5,346 | 17 | $0 (2018) |
| Phathom Pharmaceuticals, Inc. | $4,936 | 8 | $0 (2024) |
| Allergan Inc. | $4,453 | 38 | $0 (2019) |
| PALETTE LIFE SCIENCES, INC. | $4,217 | 5 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,170 | 88 | $0 (2024) |
| Janssen Biotech, Inc. | $2,328 | 85 | $0 (2024) |
| Alfasigma USA, Inc. | $2,044 | 7 | $0 (2020) |
| PFIZER INC. | $814.85 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,226 | 98 | Phathom Pharmaceuticals, Inc. ($4,936) |
| 2023 | $4,574 | 110 | PALETTE LIFE SCIENCES, INC. ($1,200) |
| 2022 | $11,185 | 131 | ABBVIE INC. ($6,025) |
| 2021 | $8,015 | 102 | AbbVie Inc. ($4,730) |
| 2020 | $7,427 | 72 | AbbVie Inc. ($4,514) |
| 2019 | $7,383 | 130 | Allergan Inc. ($2,652) |
| 2018 | $10,526 | 144 | Synergy Pharmaceuticals Inc ($5,314) |
| 2017 | $6,313 | 117 | AbbVie, Inc. ($3,392) |
All Payment Transactions
904 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $144.86 | General |
| Category: LIVER DISEASE | ||||||
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $148.04 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $31.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $117.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 11/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $47.50 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/04/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: GI | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $86.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $50.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 870 | 979 | $273,389 | $89,636 |
| 2022 | 13 | 793 | 843 | $239,545 | $76,208 |
| 2021 | 14 | 797 | 864 | $250,135 | $82,829 |
| 2020 | 15 | 839 | 961 | $226,945 | $78,115 |
Total Patients
3,299
Total Services
3,647
Medicare Billing
$326,788
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 193 | 226 | $57,856 | $21,585 | 37.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 134 | 141 | $39,762 | $12,357 | 31.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 65 | 65 | $33,995 | $11,030 | 32.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 89 | 89 | $36,490 | $8,573 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 93 | $16,926 | $6,340 | 37.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 71 | 71 | $16,685 | $5,625 | 33.7% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 43 | $11,524 | $3,824 | 33.2% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 12 | 14 | $9,520 | $3,505 | 36.8% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 18 | 18 | $7,218 | $2,683 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,450 | $2,629 | 31.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 41 | $5,904 | $2,616 | 44.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $6,534 | $2,565 | 39.3% |
| 43450 | Dilation of esophagus | Facility | 2023 | 62 | 73 | $11,753 | $2,161 | 18.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 22 | $4,532 | $1,963 | 43.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 20 | $5,020 | $1,726 | 34.4% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 20 | 20 | $1,220 | $455.12 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 161 | $41,272 | $14,974 | 36.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 86 | 86 | $44,973 | $14,689 | 32.7% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 111 | 111 | $26,120 | $9,620 | 36.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 95 | 96 | $27,080 | $8,829 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 93 | $16,935 | $5,764 | 34.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 82 | 82 | $33,632 | $5,290 | 15.7% |
| 46946 | Tying of multiple internal hemorrhoid groups | Facility | 2022 | 13 | 14 | $11,044 | $4,192 | 38.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 41 | 51 | $7,351 | $2,895 | 39.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 20 | $7,260 | $2,718 | 37.4% |
About Dr. Michael Schulman, D.O
Dr. Michael Schulman, D.O is a Gastroenterology healthcare provider based in Largo, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700971017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Schulman, D.O has received a total of $65,650 in payments from pharmaceutical and medical device companies, with $10,226 received in 2024. These payments were reported across 904 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,795).
As a Medicare-enrolled provider, Schulman has provided services to 3,299 Medicare beneficiaries, totaling 3,647 services with total Medicare billing of $326,788. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Largo, FL
- Active Since 10/03/2006
- Last Updated 11/01/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700971017
Products in Payments
- CREON (Drug) $10,160
- Trulance (Drug) $5,346
- VOQUEZNA (Drug) $4,936
- SOLESTA (Device) $4,217
- ZENPEP (Drug) $3,030
- XIFAXAN (Drug) $2,760
- TRULANCE (Drug) $2,331
- STELARA (Biological) $2,216
- LINZESS (Drug) $2,020
- Zelnorm (Drug) $2,014
- ENTYVIO (Biological) $1,371
- MOTEGRITY (Drug) $1,327
- Humira (Biological) $1,117
- SKYRIZI (Biological) $800.22
- XELJANZ (Drug) $560.00
- DUPIXENT (Biological) $557.35
- ZEPOSIA (Drug) $542.03
- Creon (Drug) $539.27
- IBSRELA (Drug) $511.03
- RINVOQ (Biological) $460.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Largo
Dr. Meir Mizrahi, Md, MD
Gastroenterology — Payments: $160,150
Gastroenterology $160,150
Huey Nguyen, M.d, M.D
Gastroenterology — Payments: $35,434
Gastroenterology $35,434
Dr. Arthur Berman, D.o., F.a.a.i.m, D.O., F.A.A.I.M
Gastroenterology — Payments: $23,357
Gastroenterology $23,357
Dr. Justin Nudell, D.o, D.O
Gastroenterology — Payments: $21,790
Gastroenterology $21,790
Dr. Marc Kudelko, D.o, D.O
Gastroenterology — Payments: $17,680
Gastroenterology $17,680
Dr. Steven Beljic, D.o, D.O
Gastroenterology — Payments: $16,596
Gastroenterology $16,596